☆GENERAL ATLANTIC, L.P.
Quality Q
0.832
AUM ($M)
2,907
Positions
12
Turnover
0.28
Top-10 wt
99%
Herfindahl
0.147
History (qtrs)
6
Excess Return
+41.5%
AI Eval Run AI Eval
Holdings · 15 positions · portfolio value $2,907M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆LFTO funds › | LIFTOFF MOBILE | NEW | — | 20.9% | +20.9% | 608.1 | 25,315,646 | +25,315,646 | 1 | -106.6% |
| ☆DLO funds › | DLOCAL | HOLD | — | 20.9% | -7.3% | 606.3 | 46,656,695 | +0 | 5 | — |
| ☆CHYM funds › | CHIME | HOLD | — | 15.0% | -3.6% | 435.4 | 21,259,683 | +0 | 5 | -39.0% |
| ☆ALKT funds › | ALKAMI | ADD | — | 12.1% | +0.9% | 351.1 | 19,379,038 | +4,041,543 | 5 | — |
| ☆XP funds › | XP, INC | HOLD | — | 11.5% | -6.7% | 334.4 | 20,566,133 | +0 | 5 | — |
| ☆PHVS funds › | PHARVARIS | TRIM | — | 7.8% | -2.8% | 226.5 | 6,550,757 | -1,480,495 | 5 | — |
| ☆SPTX funds › | SEAPORT THERAPEUTICS | NEW | — | 4.6% | +4.6% | 132.5 | 6,101,582 | +6,101,582 | 1 | +474.0% |
| ☆NRIX funds › | NURIX THERAPEUTICS | TRIM | — | 2.5% | -0.4% | 73.6 | 3,032,185 | -1,069,680 | 3 | +150.9% |
| ☆RVMD funds › | REVOLUTION MEDICINES | TRIM | — | 2.3% | -0.9% | 67.0 | 357,791 | -350,000 | 4 | +442.1% |
| ☆PBLS funds › | PARABILIS MEDICINES | NEW | — | 1.4% | +1.4% | 42.1 | 1,538,461 | +1,538,461 | 1 | +111.1% |
| ☆RSKD funds › | RISKIFIED | HOLD | — | 0.9% | -0.0% | 26.8 | 5,324,998 | +0 | 5 | — |
| ☆GROV funds › | GROVE COLLABORATIVE | HOLD | — | 0.1% | -0.0% | 3.1 | 2,474,859 | +0 | 5 | — |
| ☆CUSIP:152309100 funds › | CENTESSA PHARMACEUTICALS | EXIT | — | 0.0% | -2.5% | 0.0 | 0 | -1,354,830 | 0 | — |
| ☆BULL funds › | WEBULL | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -50,816 | 0 | -68.6% |
| ☆CUSIP:29882P106 funds › | EUROPEAN WAX CENTER | EXIT | — | 0.0% | -3.5% | 0.0 | 0 | -13,110,492 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2,907 | 12 | 0.28 | 99% | 0.147 | 0.831 | — | in |
| 2026Q1 | 2,148 | 12 | 0.17 | 100% | 0.174 | 0.919 | — | in |
| 2025Q4 | 2,873 | 13 | 0.20 | 99% | 0.138 | 0.889 | — | in |
| 2025Q3 | 3,331 | 16 | 0.12 | 96% | 0.117 | 0.943 | — | in |
| 2025Q2 | 3,630 | 15 | 0.25 | 97% | 0.140 | 0.878 | — | entered |
| 2025Q1 | 2,979 | 15 | 0.00 | 99% | 0.213 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status